Cancer News and Research

Latest Cancer News and Research

Researchers help explain why smart drugs are not effective in some cancer patients

Some of the most effective and expensive cancer drugs, dubbed "smart drugs" for their ability to stop tumors by targeting key drivers of cancer cell growth, are not effective in some patients. In two related studies, Yale School of Medicine researchers examined one such driver, the EGF receptor, and found that a decoy receptor might be limiting the amount of drug that gets to the intended target.

12 May 2011

Chemical engineer builds working models of human tissues for disease research

Shelly Peyton, a chemical engineer at the University of Massachusetts Amherst, is building working models of human bone, breast, liver and artery tissues to see how cells behave when they are affected by a disease such as cancer.

12 May 2011

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in patients having a stroke.

12 May 2011

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Trillium Therapeutics Inc., a privately-held biopharmaceutical company, announced today that it has raised $1 million from a new undisclosed investor. The funds will be used to advance its lead program, TTI-1612, into clinical trials for the treatment of interstitial cystitis, also known as bladder pain syndrome. The first trial is projected to start in the second half of this year.

12 May 2011

New organocatalyst now available for drug development industry

A new "organocatalyst" developed at Oregon State University is now available for commercial use. Produced by an Albany, Ore., pharmaceutical company, it should make new drug development around the world less costly, more efficient and more environmentally friendly.

12 May 2011

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

As one of the first medical centers in the Northwest to perform robotic-assisted surgery, Swedish is home to the fastest growing, most comprehensive and experienced robotic-assisted surgical program in the region. Swedish established the multidisciplinary, robotic-assisted surgical program in 2005 and has since performed more than 3,400 robotic-assisted surgeries -- more than any other program in the region.

12 May 2011

Biocept's paper describes identification of different CTC phenotypes in cancer patients

Biocept, Inc., a privately-held laboratory testing company focused on the detection, enumeration and analysis of circulating tumor cells (CTCs) in cancer patients, today announced the publication of a paper describing the identification of different CTC phenotypes using its proprietary Cell Enrichment and Extraction platform.

12 May 2011

Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomiting

Today Merck announced that Health Canada has approved the new intravenous formulation of EMEND IV. Used in combination with a 5-HT3 antagonist class of antiemetics and dexamethasone, fosaprepitant dimeglumine is indicated for the prevention of acute and delayed nausea and vomiting due to highly emetogenic cancer chemotherapy.

12 May 2011

Prostrate cancer patients can benefit from new MRI-ultrasound fusion

Targeted biopsy, a major advance in prostate cancer diagnostics, was detailed by a UCLA team in the current issue of Urologic Oncology. The new technology fuses MRI with real-time 3D ultrasound, providing an exacting method to obtain biopsy specimens from suspicious areas in the prostate.

12 May 2011

Noninvasive stool test can detect pancreatic cancer

Pancreatic cancer has one of the highest mortality rates of any of the major cancers, and of the 43,000-plus Americans diagnosed with the disease each year, more than 94 percent die within five years of diagnosis. One reason for this high number of deaths is a lack of effective screening tools for catching the disease early.

12 May 2011

Researchers discover Rasip1 protein that might prevent cancer metastasis

UT Southwestern Medical Center researchers have discovered a protein that guides blood vessel development and eventually might lead to a treatment to keep cancer cells from spreading.

12 May 2011

Study finds link between high prenatal BPA levels and infant's neurobehavioral abnormalities

A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.

12 May 2011

U-Systems to exhibit new version of somo•v automated breast ultrasound at SBI Meeting

U-Systems, the leader in automated breast ultrasound, will showcase significant upgrades to its somo•v Automated Breast Ultrasound System at the 10th Post Graduate Course of the Society of Breast Imaging Meeting, in San Antonio, May 18- 21.

12 May 2011

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

Cell Therapeutics, Inc. announced that data from a study with OPAXIO, in patients with newly diagnosed high-grade gliomas, and interim results from a study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia, will be presented at the 2011 American Society of Clinical Oncology Annual Meeting, which will be held June 3-7, 2011, in Chicago, Illinois. Both studies were selected for oral poster discussion sessions.

12 May 2011

VGTI, OHSU's new vaccine candidate may fight against HIV

Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute has developed a vaccine candidate in non-human primates that may eventually lead to a vaccine against Human Immunodeficiency Virus.

12 May 2011

Researchers look for surrogate endpoints to predict early benefit of cancer drugs

Great hopes are always placed in new cancer therapies. However, whether new surgical techniques, drugs or radiation therapies actually prolong the life of cancer patients, or even cure them, can often only be reliably assessed after several years' of testing. Researchers are therefore looking for proxy markers that after initiation of cancer therapy can reliably predict as quickly as possible whether the treatment has a benefit.

12 May 2011

INESC Porto, FEUP develop software to automatically analyse and validate mammograms

INESC Porto and FEUP developed software to automatically analyse and validate mammograms. The software, Semantic PACS, can be incorporated into hospital IT systems and it categorises each new mammography using automatic descriptive methods and search methods that compare the semantic contents of the images stored.

12 May 2011

INESC Porto, FC and FMUP to hold international seminar on breast cancer local treatment

The international seminar "Turning Subjective Into Objective: Cosmetic Breast Assessment of Local Treatment" will take place on 13th May starting at 9.15am. The event is organised by the Champalimaud Foundation, the Faculty of Medicine of the University of Porto and the Institute for Systems and Computer Engineering of Porto.

12 May 2011

Healthy alternatives to vitamin D

The recent increase in recommended vitamin D intake from the Food and Nutrition Board may prompt some to seek more summer sun. But, experts at The University of Texas MD Anderson Cancer Center say there's no safe amount of time people can stay in the sun without increasing skin cancer risks.

12 May 2011

iPSC-derived liver cells hold potential as alternative to liver transplants

Johns Hopkins researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.

12 May 2011

Cancer News and Research

Latest Cancer News and Research

Researchers help explain why smart drugs are not effective in some cancer patients

Chemical engineer builds working models of human tissues for disease research

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

New organocatalyst now available for drug development industry

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

Biocept's paper describes identification of different CTC phenotypes in cancer patients

Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomiting

Prostrate cancer patients can benefit from new MRI-ultrasound fusion

Noninvasive stool test can detect pancreatic cancer

Researchers discover Rasip1 protein that might prevent cancer metastasis

Study finds link between high prenatal BPA levels and infant's neurobehavioral abnormalities

U-Systems to exhibit new version of somo•v automated breast ultrasound at SBI Meeting

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

VGTI, OHSU's new vaccine candidate may fight against HIV

Researchers look for surrogate endpoints to predict early benefit of cancer drugs

INESC Porto, FEUP develop software to automatically analyse and validate mammograms

INESC Porto, FC and FMUP to hold international seminar on breast cancer local treatment

Healthy alternatives to vitamin D

iPSC-derived liver cells hold potential as alternative to liver transplants

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in